State Street’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $309K | Sell |
97,231
-18,270
| -16% | -$71.6K | ﹤0.01% | 3772 |
|
|
2025
Q4 | $497K | Buy |
115,501
+52,637
| +84% | +$472K | ﹤0.01% | 3680 |
|
|
2025
Q3 | $2.45M | Buy |
62,864
+21,335
| +51% | +$607K | ﹤0.01% | 3264 |
|
|
2025
Q2 | $969K | Buy |
41,529
+36,566
| +737% | +$865K | ﹤0.01% | 3491 |
|
|
2025
Q1 | $75.5K | Hold |
4,963
| – | – | ﹤0.01% | 4024 |
|
|
2024
Q4 | $91.1K | Sell |
4,963
-48
| -1% | -$522 | ﹤0.01% | 4007 |
|
|
2024
Q3 | $55.6K | Sell |
5,011
-11
| -0.2% | -$129 | ﹤0.01% | 4083 |
|
|
2024
Q2 | $46.6K | Sell |
5,022
-22,838
| -82% | -$545K | ﹤0.01% | 4153 |
|
|
2024
Q1 | $913K | Sell |
27,860
-498
| -2% | -$12.9K | ﹤0.01% | 3494 |
|
|
2023
Q4 | $759K | Buy |
28,358
+2,656
| +10% | +$110K | ﹤0.01% | 3540 |
|
|
2023
Q3 | $1.55M | Buy |
25,702
+161
| +0.6% | +$15.1K | ﹤0.01% | 3420 |
|
|
2023
Q2 | $2.6M | Sell |
25,541
-27,319
| -52% | -$3.76M | ﹤0.01% | 3288 |
|
|
2023
Q1 | $9.34M | Buy |
52,860
+3,507
| +7% | +$1.17M | ﹤0.01% | 2701 |
|
|
2022
Q4 | $19.1M | Sell |
49,353
-2,826
| -5% | -$1.07M | ﹤0.01% | 2273 |
|
|
2022
Q3 | $17.6M | Sell |
52,179
-2,114
| -4% | -$766K | ﹤0.01% | 2315 |
|
|
2022
Q2 | $17.8M | Buy |
54,293
+7,610
| +16% | +$2.67M | ﹤0.01% | 2334 |
|
|
2022
Q1 | $20.4M | Buy |
46,683
+5,114
| +12% | +$2.1M | ﹤0.01% | 2385 |
|
|
2021
Q4 | $18.2M | Sell |
41,569
-213
| -0.5% | -$107K | ﹤0.01% | 2542 |
|
|
2021
Q3 | $23.2M | Sell |
41,782
-3,156
| -7% | -$1.58M | ﹤0.01% | 2375 |
|
|
2021
Q2 | $23.1M | Buy |
44,938
+19,358
| +76% | +$12.3M | ﹤0.01% | 2422 |
|
|
2021
Q1 | $20M | Sell |
25,580
-1,157
| -4% | -$792K | ﹤0.01% | 2366 |
|
|
2020
Q4 | $14.6M | Buy |
26,737
+361
| +1% | +$189K | ﹤0.01% | 2421 |
|
|
2020
Q3 | $12.1M | Sell |
26,376
-1,469
| -5% | -$853K | ﹤0.01% | 2340 |
|
|
2020
Q2 | $17.1M | Sell |
27,845
-518
| -2% | -$286K | ﹤0.01% | 2116 |
|
|
2020
Q1 | $13.5M | Buy |
28,363
+594
| +2% | +$323K | ﹤0.01% | 2078 |
|
|
2019
Q4 | $16.1M | Buy |
27,769
+2,051
| +8% | +$1.44M | ﹤0.01% | 2283 |
|
|
2019
Q3 | $16.9M | Sell |
25,718
-25,209
| -50% | -$21M | ﹤0.01% | 2159 |
|
|
2019
Q2 | $39.4M | Buy |
50,927
+1,873
| +4% | +$1.32M | ﹤0.01% | 1634 |
|
|
2019
Q1 | $34.6M | Sell |
49,054
-9,924
| -17% | -$5.94M | ﹤0.01% | 1675 |
|
|
2018
Q4 | $27.6M | Sell |
58,978
-202
| -0.3% | -$130K | ﹤0.01% | 1759 |
|
|
2018
Q3 | $51M | Buy |
59,180
+11,400
| +24% | +$8.23M | ﹤0.01% | 1512 |
|
|
2018
Q2 | $32.9M | Sell |
47,780
-25,042
| -34% | -$12.7M | ﹤0.01% | 1780 |
|
|
2018
Q1 | $32.5M | Buy |
72,822
+17,857
| +32% | +$8.66M | ﹤0.01% | 1724 |
|
|
2017
Q4 | $24.2M | Sell |
54,965
-45,366
| -45% | -$20.7M | ﹤0.01% | 1915 |
|
|
2017
Q3 | $49.4M | Buy |
100,331
+10,191
| +11% | +$5.1M | ﹤0.01% | 1376 |
|
|
2017
Q2 | $49.9M | Buy |
90,140
+78,675
| +686% | +$49.9M | ﹤0.01% | 1352 |
|
|
2017
Q1 | $7.59M | Buy |
11,465
+1,784
| +18% | +$953K | ﹤0.01% | 2501 |
|
|
2016
Q4 | $3.24M | Buy |
9,681
+645
| +7% | +$207K | ﹤0.01% | 2900 |
|
|
2016
Q3 | $2.72M | Buy |
9,036
+96
| +1% | +$20.8K | ﹤0.01% | 2846 |
|
|
2016
Q2 | $1.55M | Sell |
8,940
-64
| -0.7% | -$13.9K | ﹤0.01% | 3125 |
|
|
2016
Q1 | $2.02M | Buy |
9,004
+1,149
| +15% | +$343K | ﹤0.01% | 3001 |
|
|
2015
Q4 | $4.76M | Buy |
7,855
+614
| +8% | +$337K | ﹤0.01% | 2558 |
|
|
2015
Q3 | $3.72M | Buy |
7,241
+3,959
| +121% | +$2.65M | ﹤0.01% | 2662 |
|
|
2015
Q2 | $1.44M | Buy |
3,282
+630
| +24% | +$243K | ﹤0.01% | 3165 |
|
|
2015
Q1 | $959K | Sell |
2,652
-103
| -4% | -$39K | ﹤0.01% | 3231 |
|
|
2014
Q4 | $989K | Sell |
2,755
-45
| -2% | -$14.5K | ﹤0.01% | 3266 |
|
|
2014
Q3 | $847K | Buy |
2,800
+127
| +5% | +$52.1K | ﹤0.01% | 3292 |
|
|
2014
Q2 | $1.64M | Buy |
2,673
+1,709
| +177% | +$920K | ﹤0.01% | 3127 |
|
|
2014
Q1 | $647K | Buy |
+964
| New | +$570K | ﹤0.01% | 3323 |
|
Other funds holding TVRD
SPC
VCM
AFG
SAM
DWAM
State Street's TVRD Position: Q1 2026 in Review
State Street reduced its Tvardi Therapeutics (TVRD) stake by 16% in Q1 2026, selling an estimated $71.6K and leaving 97,231 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #3772.
State Street first reported a position in TVRD in Q1 2014 and has held it in 49 quarters since. The position peaked at $51M in Q3 2018. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.
- State Street held 97,231 shares of Tvardi Therapeutics worth $309K as of Q1 2026.
- State Street sold 18,270 Tvardi Therapeutics shares in Q1 2026, an estimated $71.6K.
- Tvardi Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3772 holding.
- State Street first reported a position in Tvardi Therapeutics in Q1 2014 and has held it in 49 quarters since.
- State Street's Tvardi Therapeutics position peaked at $51M in Q3 2018.
- 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.